Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review
- PMID: 33985581
- PMCID: PMC8120816
- DOI: 10.1186/s13578-021-00602-8
Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review
Abstract
Pancreatic tumors are classified into endocrine and exocrine types, and the clinical manifestations in patients are nonspecific. Most patients, especially those with pancreatic ductal adenocarcinoma (PDAC), have lost the opportunity to receive for the best treatment at the time of diagnosis. Although chemotherapy and radiotherapy have shown good therapeutic results in other tumors, their therapeutic effects on pancreatic tumors are minimal. A multifunctional transcription factor, Yin-Yang 1 (YY1) regulates the transcription of a variety of important genes and plays a significant role in diverse tumors. Studies have shown that targeting YY1 can improve the survival time of patients with tumors. In this review, we focused on the mechanism by which YY1 affects the occurrence and development of pancreatic tumors. We found that a YY1 mutation is specific for insulinomas and has a role in driving the degree of malignancy. In addition, changes in the circadian network are a key causative factor of PDAC. YY1 promotes pancreatic clock progression and induces malignant changes, but YY1 seems to act as a tumor suppressor in PDAC and affects many biological behaviors, such as proliferation, migration, apoptosis and metastasis. Our review summarizes the progress in understanding the role of YY1 in pancreatic endocrine and exocrine tumors and provides a reasonable assessment of the potential for therapeutic targeting of YY1 in pancreatic tumors.
Keywords: Mutation; Pancreatic ductal adenocarcinoma; Pancreatic neuroendocrine tumor; Tumor suppressor; YY1.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.Cancer Lett. 2017 Nov 1;408:144-154. doi: 10.1016/j.canlet.2017.08.032. Epub 2017 Sep 1. Cancer Lett. 2017. PMID: 28867247
-
Suppressive effect of YY1-mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma.Oncol Lett. 2022 Nov 2;24(6):457. doi: 10.3892/ol.2022.13577. eCollection 2022 Dec. Oncol Lett. 2022. PMID: 36380881 Free PMC article.
-
YY1 inhibits the migration and invasion of pancreatic ductal adenocarcinoma by downregulating the FER/STAT3/MMP2 signaling pathway.Cancer Lett. 2019 Oct 28;463:37-49. doi: 10.1016/j.canlet.2019.07.019. Epub 2019 Aug 9. Cancer Lett. 2019. PMID: 31404611
-
The Yin and Yang of YY1 in tumor growth and suppression.Int J Cancer. 2018 Aug 1;143(3):460-465. doi: 10.1002/ijc.31255. Epub 2018 Jan 31. Int J Cancer. 2018. PMID: 29322514 Review.
-
Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.Cancers (Basel). 2023 Jul 5;15(13):3506. doi: 10.3390/cancers15133506. Cancers (Basel). 2023. PMID: 37444616 Free PMC article. Review.
Cited by
-
Report of a Novel Molecular Profile in Malignant Insulinoma.J Clin Med. 2023 Feb 6;12(4):1280. doi: 10.3390/jcm12041280. J Clin Med. 2023. PMID: 36835815 Free PMC article.
-
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms.Biomedicines. 2023 Jan 21;11(2):303. doi: 10.3390/biomedicines11020303. Biomedicines. 2023. PMID: 36830839 Free PMC article. Review.
-
Ferroptosis in pancreatic diseases: potential opportunities and challenges that require attention.Hum Cell. 2023 Jul;36(4):1233-1243. doi: 10.1007/s13577-023-00894-7. Epub 2023 Mar 16. Hum Cell. 2023. PMID: 36929283 Review.
-
Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star.Cell Biosci. 2022 Jun 21;12(1):97. doi: 10.1186/s13578-022-00833-3. Cell Biosci. 2022. PMID: 35729650 Free PMC article. Review.
-
Ferroptosis: potential targets and emerging roles in pancreatic diseases.Arch Toxicol. 2024 Jan;98(1):75-94. doi: 10.1007/s00204-023-03625-x. Epub 2023 Nov 7. Arch Toxicol. 2024. PMID: 37934210 Review.
References
-
- Henry BM, Skinningsrud B, Saganiak K, Pękala PA, Walocha JA, Tomaszewski KA. Development of the human pancreas and its vasculature - an integrated review covering anatomical, embryological, histological, and molecular aspects. Ann Anat. 2019;221:115–124. doi: 10.1016/j.aanat.2018.09.008. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources